KITELVY Trademark

Trademark Overview

On Monday, April 14, 2025, a trademark application was filed for KITELVY with the United States Patent and Trademark Office. The USPTO has given the KITELVY trademark a serial number of 99135823. The federal status of this trademark filing is ABANDONED - EXPRESS as of Saturday, March 7, 2026. This trademark is owned by Cogent Biosciences, Inc.. The KITELVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
kitelvy

General Information

Serial Number99135823
Word MarkKITELVY
Filing DateMonday, April 14, 2025
Status601 - ABANDONED - EXPRESS
Status DateSaturday, March 7, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases or conditions mediated by a c-kit or mutant c-kit protein kinase
Translation of Words in MarkThe wording "KITELVY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCogent Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
US

Trademark Events

Event DateEvent Description
Monday, April 14, 2025NEW APPLICATION ENTERED
Monday, April 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 14, 2025APPLICATION FILING RECEIPT MAILED
Friday, May 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 9, 2025ASSIGNED TO EXAMINER
Monday, September 15, 2025NON-FINAL ACTION WRITTEN
Monday, September 15, 2025NON-FINAL ACTION E-MAILED
Monday, September 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 13, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, November 13, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, November 13, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, November 13, 2025EXAMINER'S AMENDMENT ENTERED
Monday, November 17, 2025LETTER OF PROTEST EVIDENCE FORWARDED
Monday, November 17, 2025LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
Tuesday, December 2, 2025NON-FINAL ACTION WRITTEN
Tuesday, December 2, 2025NON-FINAL ACTION E-MAILED
Tuesday, December 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 26, 2026APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, February 26, 2026APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, March 6, 2026TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, March 7, 2026ABANDONMENT - EXPRESS MAILED
Saturday, March 7, 2026ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Related Keywords

kitelvy mutant protein kinase mediated conditions preparations treatment diseases pharmaceutical